Results 141 to 150 of about 120,253,457 (190)

Management of donor-specific antibodies in allogeneic hematopoietic cell transplantation: A retrospective single-center case-control study. [PDF]

open access: yesCell Transplant
Harland L   +10 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Removal of antiacetylcholine receptor antibodies by protein-A immunoadsorption in myasthenia gravis

open access: yesInternational Journal of Artificial Organs, 1994
Myasthenia Gravis is an autoimmune disease in which autoantibodies to the acetylcholine receptor interfere with neuromuscular transmission. Plasma exchange is effective in temporarily relieving the symptoms of the disease, but for repeated use the lack ...
E. Berta   +7 more
semanticscholar   +2 more sources

Severe Adverse Effects of Protein A Immunoadsorption

Lancet, The, 1994
Bettina Wedi, V Kiefel, H Kroll
exaly   +2 more sources

Protein A Immunoadsorption Relieves Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy after Unsuccessful Methylprednisolone Treatment

Neuroimmunomodulation, 2021
Background: Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy (GFAP-A) is a recently defined autoimmune inflammatory disease of the central nervous system in which GFAP IgG is present in the cerebrospinal fluid (CSF).
B. Qin   +6 more
semanticscholar   +1 more source

Protein A immunoadsorption in the treatment of malignant disease.

open access: yesJournal of Clinical Oncology, 1988
Circulating immune complexes (CIC) are known to be present in cancer patients and are responsible for much of the cancer-associated immunosuppression. Removal or modulation of these "blocking factors" can reverse the immunosuppression.
G. Messerschmidt   +9 more
semanticscholar   +2 more sources

Home - About - Disclaimer - Privacy